Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
196 Results Found
HHS finalizes rule on 340B Administrative Dispute Resolution process
The Department of Health and Human Services April 18 finalized its rule to establish a 340B Administrative Dispute Resolution process as required under the Affordable Care Act.
Senator Thune touts support for telehealth, urges solution-oriented advocacy
Sen. John Thune, R-S.D., April 16 updated AHA members on progress to extend telehealth waivers, offering hope that a solution will arise in end-of-year legislation that Congress will attempt to pass.
AHA comments on draft Senate bill to clarify, protect 340B program
AHA March 26 submitted comments on a discussion draft of the SUSTAIN 340B Act, legislation proposed in the Senate to clarify Congress’ intent in creating the 340B program and protect 340B providers from egregious behavior by drug companies, insurers and pharmacy benefit managers.
New Healthsperien report finds that 340B drug discounts are a small share of drug company revenues
AHA March 12 released a new report from Healthsperien on discounts to 340B hospitals through the 340B Drug Pricing Program relative to drug company revenues and revenue growth.
As urged by the AHA, 8th Circuit upholds Arkansas law protecting 340B contract pharmacy arrangements
The U.S. Court of Appeals for the 8th Circuit March 12 upheld Arkansas’ 340B Drug Pricing Nondiscrimination Act against a constitutional challenge brought by the Pharmaceutical Research and Manufacturers of America, ruling that the Federal Food, Drug, and Cosmetic Act does not preempt the state law.
AHA files brief defending Louisiana 340B contract pharmacy law
AHA Feb. 29 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies, its latest in a string of lawsuits claiming the federal law that created the 340B program preempts the state law.
New Error-Ridden 340B Study Misses the Mark
A new study published in the New England Journal of Medicine demonstrates a stunning lack of understanding of the 340B drug pr
Senators seek stakeholder feedback on draft 340B legislation
A bipartisan group of senators Feb. 2 released for stakeholder feedback a discussion draft of legislation to clarify in statute Congress’ intent for the 340B program to help safety net providers maintain, improve and expand patient access to health care services by requiring drug manufacturers that participate in Medicaid and Medicare Part B to provide discounts and rebates to covered entities that serve a disproportionate share of low-income and underserved patients.
AHA files friend-of-the-court brief defending Louisiana 340B contract pharmacy law
AHA Dec. 22 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
HHS issues final remedy for its unlawful 340B payment cuts from 2018 to 2022
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.